Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1992 Mar;215(3):256–260. doi: 10.1097/00000658-199203000-00010

Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect.

W Timens 1, R Leemans 1
PMCID: PMC1242429  PMID: 1543398

Abstract

The risk of severe infections after splenectomy, even after many years, is now well established. In attempts to prevent these infections, spleen-saving techniques, including autotransplantation of spleen fragments, have been performed, when possible in combination with vaccination. The problem in autotransplantation is the evaluation of functional activity. The results of the tests used until now often do not seem to correlate very well with the risk of developing an overwhelming postsplenectomy infection (OPSI). This may be related to the fact that the tests used evaluate general functions, and not specific spleen-related functions, such as the capacity to mount a primary response to certain polysaccharide antigens present in the capsule of bacteria known to cause OPSI. In this review, the significance of the spleen in the human immune system is discussed and the effects of splenectomy are described, including the precautions that can be taken to diminish the risk of postsplenectomy infections and sepsis. It appears that postsplenectomy vaccination is more successful when recently developed protein-conjugated polysaccharide vaccines are used. Because the present testing of the function of spleen autotransplants is not adequate, we suggest that new tests should be developed, employing appropriate polysaccharide antigens.

Full text

PDF
256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaberge I. S., Heier H. E., Hem E., Giercksky K. E., Groeng E. C. IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma. Acta Pathol Microbiol Immunol Scand C. 1984 Feb;92(1):11–16. doi: 10.1111/j.1699-0463.1984.tb00046.x. [DOI] [PubMed] [Google Scholar]
  2. Amlot P. L., Grennan D., Humphrey J. H. Splenic dependence of the antibody response to thymus-independent (TI-2) antigens. Eur J Immunol. 1985 May;15(5):508–512. doi: 10.1002/eji.1830150516. [DOI] [PubMed] [Google Scholar]
  3. Amlot P. L., Hayes A. E. Impaired human antibody response to the thymus-independent antigen, DNP-Ficoll, after splenectomy. Implications for post-splenectomy infections. Lancet. 1985 May 4;1(8436):1008–1011. doi: 10.1016/s0140-6736(85)91613-7. [DOI] [PubMed] [Google Scholar]
  4. Anderson P. W., Pichichero M. E., Insel R. A., Betts R., Eby R., Smith D. H. Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant. J Immunol. 1986 Aug 15;137(4):1181–1186. [PubMed] [Google Scholar]
  5. Anderson P., Pichichero M. E., Insel R. A. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b. J Pediatr. 1985 Sep;107(3):346–351. doi: 10.1016/s0022-3476(85)80504-7. [DOI] [PubMed] [Google Scholar]
  6. Bohnsack J. F., Brown E. J. The role of the spleen in resistance to infection. Annu Rev Med. 1986;37:49–59. doi: 10.1146/annurev.me.37.020186.000405. [DOI] [PubMed] [Google Scholar]
  7. Brivet F., Herer B., Fremaux A., Dormont J., Tchernia G. Fatal post-splenectomy pneumococcal sepsis despite pneumococcal vaccine and penicillin prophylaxis. Lancet. 1984 Aug 11;2(8398):356–357. doi: 10.1016/s0140-6736(84)92729-6. [DOI] [PubMed] [Google Scholar]
  8. Claassen E., Kors N., Dijkstra C. D., Van Rooijen N. Marginal zone of the spleen and the development and localization of specific antibody-forming cells against thymus-dependent and thymus-independent type-2 antigens. Immunology. 1986 Mar;57(3):399–403. [PMC free article] [PubMed] [Google Scholar]
  9. Claassen E., Kors N., Van Rooijen N. Influence of carriers on the development and localization of anti-2,4,6-trinitrophenyl (TNP) antibody-forming cells in the murine spleen. II. Suppressed antibody response to TNP-Ficoll after elimination of marginal zone cells. Eur J Immunol. 1986 May;16(5):492–497. doi: 10.1002/eji.1830160505. [DOI] [PubMed] [Google Scholar]
  10. Claassen E., Ott A., Boersma W. J., Deen C., Schellekens M. M., Dijkstra C. D., Kors N., Van Rooijen N. Marginal zone of the murine spleen in autotransplants: functional and histological observations in the response against a thymus-independent type 2 antigen. Clin Exp Immunol. 1989 Sep;77(3):445–451. [PMC free article] [PubMed] [Google Scholar]
  11. Cohn D. A., Schiffman G. Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens. Infect Immun. 1987 Jun;55(6):1375–1380. doi: 10.1128/iai.55.6.1375-1380.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Di Padova F., Dürig M., Harder F., Di Padova C., Zanussi C. Impaired antipneumococcal antibody production in patients without spleens. Br Med J (Clin Res Ed) 1985 Jan 5;290(6461):14–16. doi: 10.1136/bmj.290.6461.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Drew P. A., Kiroff G. K., Ferrante A., Cohen R. C. Alterations in immunoglobulin synthesis by peripheral blood mononuclear cells from splenectomized patients with and without splenic regrowth. J Immunol. 1984 Jan;132(1):191–196. [PubMed] [Google Scholar]
  14. Eibl M. Immunological consequences of splenectomy. Prog Pediatr Surg. 1985;18:139–145. doi: 10.1007/978-3-642-70276-1_18. [DOI] [PubMed] [Google Scholar]
  15. Eskola J., Käyhty H., Peltola H., Karanko V., Mäkelä P. H., Samuelson J., Gordon L. K. Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet. 1985 May 25;1(8439):1184–1186. doi: 10.1016/s0140-6736(85)92863-6. [DOI] [PubMed] [Google Scholar]
  16. Eskola J., Peltola H., Takala A. K., Käyhty H., Hakulinen M., Karanko V., Kela E., Rekola P., Rönnberg P. R., Samuelson J. S. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med. 1987 Sep 17;317(12):717–722. doi: 10.1056/NEJM198709173171201. [DOI] [PubMed] [Google Scholar]
  17. Evans D. I. Fatal post-splenectomy sepsis despite prophylaxis with penicillin and pneumococcal vaccine. Lancet. 1984 May 19;1(8386):1124–1124. doi: 10.1016/s0140-6736(84)92537-6. [DOI] [PubMed] [Google Scholar]
  18. Fasching M. C., Cooney D. R. Reimmunization and splenic autotransplantation: a long-term study of immunologic response and survival following pneumococcal challenge. J Surg Res. 1980 May;28(5):449–459. doi: 10.1016/0022-4804(80)90109-2. [DOI] [PubMed] [Google Scholar]
  19. Feliciano D. V., Spjut-Patrinely V., Burch J. M., Mattox K. L., Bitondo C. G., Cruse-Martocci P., Jordan G. L., Jr Splenorrhaphy. The alternative. Ann Surg. 1990 May;211(5):569–582. doi: 10.1097/00000658-199005000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Giebink G. S., Foker J. E., Kim Y., Schiffman G. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis. 1980 Mar;141(3):404–412. doi: 10.1093/infdis/141.3.404. [DOI] [PubMed] [Google Scholar]
  21. Gray D., Chassoux D., MacLennan I. C., Bazin H. Selective depression of thymus-independent anti-DNP antibody responses induced by adult but not neonatal splenectomy. Clin Exp Immunol. 1985 Apr;60(1):78–86. [PMC free article] [PubMed] [Google Scholar]
  22. Humphrey J. H., Grennan D. Different macrophage populations distinguished by means of fluorescent polysaccharides. Recognition and properties of marginal-zone macrophages. Eur J Immunol. 1981 Mar;11(3):221–228. doi: 10.1002/eji.1830110311. [DOI] [PubMed] [Google Scholar]
  23. Humphrey J. H. Splenic macrophages: antigen presenting cells for T1-2 antigens. Immunol Lett. 1985;11(3-4):149–152. doi: 10.1016/0165-2478(85)90161-0. [DOI] [PubMed] [Google Scholar]
  24. Humphrey J. H. Tolerogenic or immunogenic activity of hapten-conjugated polysaccharides correlated with cellular localization. Eur J Immunol. 1981 Mar;11(3):212–220. doi: 10.1002/eji.1830110310. [DOI] [PubMed] [Google Scholar]
  25. Insel R. A., Anderson P. W. Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine. N Engl J Med. 1986 Aug 21;315(8):499–503. doi: 10.1056/NEJM198608213150807. [DOI] [PubMed] [Google Scholar]
  26. KING H., SHUMACKER H. B., Jr Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg. 1952 Aug;136(2):239–242. doi: 10.1097/00000658-195208000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Leonard A. S., Giebink G. S., Baesl T. J., Krivit W. The overwhelming postsplenectomy sepsis problem. World J Surg. 1980 Jul;4(4):423–432. doi: 10.1007/BF02393164. [DOI] [PubMed] [Google Scholar]
  28. Lewis S. M. The spleen--mysteries solved and unresolved. Clin Haematol. 1983 Jun;12(2):363–373. [PubMed] [Google Scholar]
  29. Lockwood C. M. Immunological functions of the spleen. Clin Haematol. 1983 Jun;12(2):449–465. [PubMed] [Google Scholar]
  30. Mitchell A., Morris P. J. Surgery of the spleen. Clin Haematol. 1983 Jun;12(2):565–590. [PubMed] [Google Scholar]
  31. Mizrahi S., Bickel A., Haj M., Lunski I., Shtamler B. Posttraumatic autotransplantation of spleen tissue. Arch Surg. 1989 Jul;124(7):863–865. doi: 10.1001/archsurg.1989.01410070123025. [DOI] [PubMed] [Google Scholar]
  32. Moore G. E., Stevens R. E., Moore E. E., Aragon G. E. Failure of splenic implants to protect against fatal postsplenectomy infection. Am J Surg. 1983 Sep;146(3):413–414. doi: 10.1016/0002-9610(83)90430-0. [DOI] [PubMed] [Google Scholar]
  33. Najjar V. A., Nishioka K. "Tuftsin": a natural phagocytosis stimulating peptide. Nature. 1970 Nov 14;228(5272):672–673. doi: 10.1038/228672a0. [DOI] [PubMed] [Google Scholar]
  34. Nieuwenhuis P., Ford W. L. Comparative migration of B- and T-Lymphocytes in the rat spleen and lymph nodes. Cell Immunol. 1976 May;23(2):254–267. doi: 10.1016/0008-8749(76)90191-x. [DOI] [PubMed] [Google Scholar]
  35. Oldfield S., Jenkins S., Yeoman H., Gray D., MacLennan I. C. Class and subclass anti-pneumococcal antibody responses in splenectomized patients. Clin Exp Immunol. 1985 Sep;61(3):664–673. [PMC free article] [PubMed] [Google Scholar]
  36. Pabst R. The spleen in lymphocyte migration. Immunol Today. 1988 Feb;9(2):43–45. doi: 10.1016/0167-5699(88)91258-3. [DOI] [PubMed] [Google Scholar]
  37. Patel J. M., Williams J. S., Naim J. O., Hinshaw J. R. The effect of site and technique of splenic tissue reimplantation on pneumococcal clearance from the blood. J Pediatr Surg. 1986 Oct;21(10):877–880. doi: 10.1016/s0022-3468(86)80012-4. [DOI] [PubMed] [Google Scholar]
  38. Pedersen F. K., Henrichsen J., Schiffman G. Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children. Acta Paediatr Scand. 1982 May;71(3):451–455. doi: 10.1111/j.1651-2227.1982.tb09451.x. [DOI] [PubMed] [Google Scholar]
  39. Pneumococcal vaccine failure. N Engl J Med. 1987 May 14;316(20):1272–1273. doi: 10.1056/NEJM198705143162010. [DOI] [PubMed] [Google Scholar]
  40. Rice H. M., James P. D. Ectopic splenic tissue failed to prevent fatal pneumococcal septicaemia after splenectomy for trauma. Lancet. 1980 Mar 15;1(8168 Pt 1):565–566. doi: 10.1016/s0140-6736(80)91056-9. [DOI] [PubMed] [Google Scholar]
  41. Sherman R. Perspectives in management of trauma to the spleen: 1979 presidential address, American Association for the Surgery of Trauma. J Trauma. 1980 Jan;20(1):1–13. [PubMed] [Google Scholar]
  42. Sullivan J. L., Ochs H. D., Schiffman G., Hammerschlag M. R., Miser J., Vichinsky E., Wedgwood R. J. Immune response after splenectomy. Lancet. 1978 Jan 28;1(8057):178–181. doi: 10.1016/s0140-6736(78)90612-8. [DOI] [PubMed] [Google Scholar]
  43. Timens W., Boes A., Poppema S. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation. Eur J Immunol. 1989 Nov;19(11):2163–2166. doi: 10.1002/eji.1830191129. [DOI] [PubMed] [Google Scholar]
  44. Timens W., Boes A., Rozeboom-Uiterwijk T., Poppema S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol. 1989 Nov 15;143(10):3200–3206. [PubMed] [Google Scholar]
  45. Timens W., Poppema S. Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease. Am J Pathol. 1985 Sep;120(3):443–454. [PMC free article] [PubMed] [Google Scholar]
  46. Traub A., Giebink G. S., Smith C., Kuni C. C., Brekke M. L., Edlund D., Perry J. F. Splenic reticuloendothelial function after splenectomy, spleen repair, and spleen autotransplantation. N Engl J Med. 1987 Dec 17;317(25):1559–1564. doi: 10.1056/NEJM198712173172503. [DOI] [PubMed] [Google Scholar]
  47. Wara D. W. Host defense against Streptococcus pneumoniae: the role of the spleen. Rev Infect Dis. 1981 Mar-Apr;3(2):299–309. doi: 10.1093/clinids/3.2.299. [DOI] [PubMed] [Google Scholar]
  48. Westermann J., Pabst R. Autotransplantation of splenic fragments: lymphocyte subsets in blood, lymph nodes and splenic tissue. Clin Exp Immunol. 1986 Apr;64(1):188–194. [PMC free article] [PubMed] [Google Scholar]
  49. van der Woude F. J., Beekhuis H., Beelen J. M., The T. H. Kinetic analysis of the blood clearance and organ uptake curves of IgG-coated red cells in HLA-typed controls and patients with Wegener's granulomatosis. Eur J Nucl Med. 1986;12(3):130–136. doi: 10.1007/BF00276705. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES